ArticleHuman vaccines & immunotherapeutics2023

Long-lasting complete response to SHR-1701 plus famitinib in refractory advanced gallbladder cancer: A case report.

Lixia Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.